Skip to content
Home/Companies/Biotech/PearlRiver Bio

PearlRiver Bio

Biotech·Germany·Exited 2022·Held 2yr
Entry
2020
Hold
2yr
Exit
2022

Who owns PearlRiver Bio?

PearlRiver Bio was owned by TVM Capital Life Science through TVM Life Science Ventures (2004 vintage) from 2020 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Ventures · 2004 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from TVM Life Science Ventures

Other portfolio companies in the same fund.

CSA Medical, Inc.
Active
MedTechUnited States· 2024
Jacobian GmbH
Jacobian GmbH
Active
HealthTechGermany· 2024
Myosotis GmbH
Active
HealthTechGermany· 2024
Vektor Medical, Inc.
Active
MedTechUnited States· 2024
Zevra Therapeutics
Zevra Therapeutics
Active
PharmaUnited States· 2023
Egg Medical
Egg Medical
Active
MedTechUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track PearlRiver Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PearlRiver Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue